Clinical Trials
6 trialsNCT02789345 2024-02-05
A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer
Eli Lilly and Company
Phase 1 Completed
NCT03360734 2021-07-12
GATTO
Glycotope GmbH
Phase 1 Completed
NCT02451930 2020-10-05
A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC
Eli Lilly and Company
Phase 1 Completed
NCT02411591 2020-07-09
A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)
Eli Lilly and Company
Phase 1 Completed
NCT01088464 2017-02-03
Study of IMC-11F8 in Participants With Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Completed
NCT00801177 2010-10-13
Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy
Eli Lilly and Company
Phase 1 Completed